Event Details
Event Title Medicine Grand Rounds - Collateral Damage: Characterizing Immune Checkpoint Inhibitor Toxicities
Groups Hematology Oncology
Event Start Date 05/16/2019 08:00 AM
Event Duration 1 hour
Location 208 Light Hall
Speaker Doug Johnson, M.D., M.S.C.I.
Event Details Douglas Johnson, MD, MSCI received his MD from the University of Alabama School of Medicine and completed internal medicine residency at Duke University before coming to Vanderbilt for hematology/oncology fellowship. He has been on faculty at Vanderbilt since 2014 as an Assistant Professor of Medicine and is now the director of the melanoma clinical and research program. Dr. Johnson’s research focuses on optimizing and extending the use of novel immune and targeted therapies in melanoma, to identify markers of response and resistance, to understand and more effectively manage the side effects of these new therapies, and to develop new treatment options for melanoma. He is the local and national principal investigator for numerous clinical trials and his research is funded by individual philanthropy, National Cancer Institute, the American Society of Clinical Oncology, the National Comprehensive Cancer Network, and the Melanoma Research Foundation. He also has national leadership positions, including membership in the NCCN Melanoma Guidelines Committee.
Credit Hours yes
Additional Comments Our presenter is a consultant for Bristol-Myers Squibb, Merck and Company, Inc, Array Biopharma and Incyte. The CME Division has determined there is no conflict of interest.
Who May Attend The Medicine Community
Meals No
Refreshments Yes
Sponsored by Vanderbilt School of Medicine; Department of Medicine. Vanderbilt School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Vanderbilt School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. It is the policy of Vanderbilt School of Medicine that participants in CME activities be made aware of any affiliation or financial interest that may affect the planner’s involvement and speaker’s presentation(s). Each planner and speaker has completed and signed a conflict of interest statement; these relationships will be disclosed to the audience. This educational activity received no commercial support. The Division of CME
Back to Calendar View